NOTE 5 - CONVERTIBLE NOTES PAYABLE, NET (Details) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
|
| Convertible Notes Payable, Current | $ 113,766 | $ 102,072 | |
| Convertible notes payable, long-term, net of $963 and $0 debt discount, respectively | 443,137 | 434,100 | |
| Convertible notes payable, current, net of $20,789 and $32,483 debt discount, respectively. $45,000 in default | 113,766 | 102,072 | |
| Accrued interest payable | 142,623 | 129,229 | |
| Convertible Notes Payable | 556,903 | 536,172 | |
| Debt Instrument, Unamortized Discount, Current | 20,789 | 32,483 | |
| Convertible Debt | |||
| Interest Expense, Debt | 1,998 | $ 1,998 | |
| Accrued interest payable | 70,615 | 68,617 | |
| Convertible Note Payable | |||
| Convertible notes payable, current, net of $20,789 and $32,483 debt discount, respectively. $45,000 in default | $ 45,000 | ||
| Equity Financing Description | The note, together with all unpaid accrued interest, is automatically convertible in full upon the closing of a qualified financing. A qualified financing is defined as an equity financing resulting in gross proceeds to the Company of at least $750,000, including the conversion of this note and other debt. Upon a qualified financing, the conversion price would be equal to 100% of the per-share price paid by investors in the financing, subject to valuation adjustments ranging from a minimum valuation of $15.0 million to a maximum valuation of $30.0 million. We reviewed this conversion feature under ASC 815 and determined no derivative accounting was required. See Note 8. | ||
| Convertible Notes Payable | $ 45,000 | 45,000 | |
| Series 2023 Convertible Notes | |||
| Interest Expense, Debt | 838 | 840 | |
| Accrued interest payable | 9,387 | 8,549 | |
| Convertible Notes Payable | $ 34,000 | 34,000 | |
| Series 2025 Notes Mandatorily Convertible Notes | |||
| Equity Financing Description | These notes are substantially similar to the Series 2023 Notes, except that they convert at 50% of the applicable offering price, or if the Company’s common stock trades at or above $1.00 ($0.50 for the March 18 Note) for 10 consecutive trading days, in which case they convert at 50% of the closing price on the tenth day. | ||
| Interest Expense, Debt | $ 11,061 | $ 234 | |
| Convertible Notes Payable | 434,100 | ||
| November 2025 Convertible Promissory Note | |||
| Interest Expense, Debt | 2,123 | ||
| Accrued interest payable | 3,402 | 1,279 | |
| Convertible Notes Payable | 34,766 | $ 23,072 | |
| Proceeds from issuance of convertible notes payable | 50,000 | ||
| Debt discount at inception of derivative | 29,647 | ||
| Debt Instrument, Unamortized Discount, Current | 20,789 | ||
| Amortization of Debt Discount Recognized as Interest Expense | $ 11,731 | ||
| Series 2026 Notes Mandatorily Convertible Notes | |||
| Equity Financing Description | During the three months ended March 31, 2026, the Company issued a new note for $10,000, denoted as Series 2026 Notes. These notes are identical to the Series 2025 Notes. The derivative liability was recognized at fair value of $1,000 on the issuance date and was recorded as a debt discount which is being amortized over the term of the note using the effective interest method. The derivative liability is subsequently remeasured at fair value at each reporting period, with changes in fair value recognized in the consolidated statement of operations. As of March 31, 2026, the derivative liability associated with this note is included in Derivative liabilities – convertible instruments on the consolidated balance sheet (see Note 8). As of March 31, 2026, the net carrying amount of this note was $9,037 and the debt discount was $963. | ||
| Interest Expense, Debt | $ 177 | ||
| Accrued interest payable | $ 177 | ||